Vera Therapeutics, Inc. · 4 months ago
Senior Director, Clinical Development
Vera Therapeutics is a late clinical-stage biotechnology company focused on developing treatments for serious immunological diseases. The Senior Director, Clinical Development will lead ongoing clinical research programs, ensuring the strategic planning, protocol design, and execution of clinical trials while maintaining the medical and scientific integrity of the company.
BiotechnologyHealth Care
Responsibilities
Serve as Clinical Lead for one or more clinical programs from early- through late-stage development, contributing to strategic planning, protocol design, and execution
Analyze and interpret clinical trial data, ensuring appropriate actions are taken to advance development programs and inform corporate decision-making
Lead or support the development of key regulatory documents (e.g., INDs, NDAs, CTAs), study reports, and publications; represent the clinical program in health authority interactions
Provides oversight and medical accountability for multiple trials across early development clinical lifecycle
Assesses safety-related adverse events in partnership with Global Safety and oversees contributions to safety narratives
Strong presentation skills for internal and external (Investigator meetings, DMCs, Steering Committee) communications
Accountable as a key medical and scientific leader
Represent the medical and scientific integrity of the company, leading science-driven product development and informing clinically related corporate decisions
Ensure clinical programs meet required quality and safety standards
Medical review of clinical documents submitted to regulatory agencies
Participate in meetings with regulatory agencies as clinical program leader
Lead publication strategy in close collaboration with relevant internal functions
Lead interactions and build relationships with medical and scientific advisors, building and maintaining relationships consistent with development and commercial objectives
Qualification
Required
M.D. (U.S. board-certified) with subspecialty training or experience in Nephrology or Rheumatology/Immunology strongly preferred
4+ years of clinical development experience in the pharmaceutical, biotech, or academic research setting
In-depth knowledge of clinical trial design, data analysis, and interpretation in late-stage development
Strong written and verbal communication skills, with the ability to distill complex clinical data for a range of stakeholders
Proven ability to work collaboratively in a matrixed, cross-functional team environment
High integrity, sound judgment, and a passion for advancing transformative therapies
Company
Vera Therapeutics, Inc.
Vera Therapeutics, Inc.
Funding
Current Stage
Public CompanyTotal Funding
$1.23BKey Investors
Oxford Finance LLCAbingworth
2025-12-09Post Ipo Equity· $261M
2025-06-03Post Ipo Debt· $75M
2024-10-28Post Ipo Equity· $300M
Leadership Team
Recent News
2026-01-11
The Motley Fool
2026-01-08
Company data provided by crunchbase